Cellcentric Ltd.
Clinical trials sponsored by Cellcentric Ltd., explained in plain language.
-
New hope for blood cancer patients: experimental drug enters human trials
Disease control Recruiting nowThis study tests a new drug called CCS1477 in people with advanced blood cancers like leukemia, lymphoma, and multiple myeloma. The goal is to see if the drug is safe and can help control the disease. About 250 participants will receive the drug alone or with other treatments.
Phase: PHASE1, PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New drug cocktail targets Hard-to-Treat myeloma
Disease control Recruiting nowThis study tests a new drug, inobrodib, combined with two standard medicines (pomalidomide and dexamethasone) in 100 adults whose multiple myeloma has come back or no longer responds to available therapies. The goal is to see how well the combination shrinks or controls the cance…
Phase: PHASE2 • Sponsor: CellCentric Ltd. • Aim: Disease control
Last updated Jun 10, 2026 13:27 UTC